✦ LIBER ✦

Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. A pilot study

✍ Scribed by Susy M. Scholl; Rosette Lidereau; Anne de la Rochefordière; Christine Cohen-Solal Le-Nir; Véronique Mosseri; Catherine Noguès; Pierre Pouillart; E. Richard Stanley

Publisher: Springer US
Year: 1996
Tongue: English
Weight: 742 KB
Volume: 39
Category: Article
ISSN: 0167-6806
DOI: 10.1007/bf01806155

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enhancement of myeloperoxidase activity

Enhancement of myeloperoxidase activity in WBCS in oral cancer patients treated with Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)—A pilot study

✍ N. Ananth; Ganesh B. Balaji; D. M. Vasudevan; Vivian D’Souza; Ashalatha V. Rao; 📂 Article 📅 1998 🏛 Association of Clinical Biochemistry of India 🌐 English ⚖ 192 KB

Beneficial impact of peripheral blood pr

Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor a randomized trial

✍ Alan Kritz; John P. Crown; Robert J. Motzer; Lilian M. Reich; Glenn Heller; Mich 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 672 KB

Erythropoietin and granulocyte-macrophag

Erythropoietin and granulocyte-macrophage colony-stimulating factor allow acceleration and dose escalation of cyclophosphamide/epidoxorubicin/5-fluorouracil chemotherapy: a dose-finding study in patients with advanced breast cancer

✍ M. Venturini; L. Del Mastro; Franco Testore; Marco Danova; Ornella Garrone; Clau 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 160 KB

Phase II study of mitoxantrone by 14-day

Phase II study of mitoxantrone by 14-day continuous infusion with granulocyte colony-stimulating factor (GCSF) support in patients with metastatic breast cancer and limited prior therapy

✍ Lajos Pusztai; Frankie A. Holmes; Giuseppe Fraschini; Gabriel N. Hortobagyi 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 142 KB

Granulocyte-colony stimulating factor in

Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4)¶ Protocol for a controlled clinical trial developed by consensus of an international study group¶ Part two: design of the study

✍ A. Bauhofer; W. Lorenz; B. Stinner; M. Rothmund; M. Koller; H. Sitter; I. Celik; 📂 Article 📅 2001 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 242 KB

Granulocyte-colony stimulating factor in

Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4)¶ Protocol of a controlled clinical trial developed by consensus of an international study group¶ Part three: individual patient, complication algorithm and quality management¶

✍ B. Stinner; A. Bauhofer; W. Lorenz; M. Rothmund; U. Plaul; A. Torossian; I. Celi 📂 Article 📅 2001 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 218 KB